7-107474251-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_005295.3(GPR22):c.191T>C(p.Val64Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,612,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005295.3 missense
Scores
Clinical Significance
Conservation
Publications
- COG5-congenital disorder of glycosylationInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GPR22 | ENST00000304402.6 | c.191T>C | p.Val64Ala | missense_variant | Exon 3 of 3 | 1 | NM_005295.3 | ENSP00000302676.4 | ||
| COG5 | ENST00000297135.9 | c.538+52986A>G | intron_variant | Intron 6 of 21 | 1 | NM_006348.5 | ENSP00000297135.4 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 152036Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 250712 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1460594Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 726640 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74410 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.191T>C (p.V64A) alteration is located in exon 3 (coding exon 1) of the GPR22 gene. This alteration results from a T to C substitution at nucleotide position 191, causing the valine (V) at amino acid position 64 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at